In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Alphatec Holdings Inc.

https://atecspine.com/

Latest From Alphatec Holdings Inc.

$1bn Deal Boosts Takeda, Arrowhead’s Liver Disease And RNAi Ambitions

Takeda's global deal for one of US RNAi specialist's lead assets follows recent promising clinical results in serious disorder with no current therapeutic options.

Commercial Deals

COVID-19 Contracting Accelerated As US Fiscal Year 2020 Drew To A Close

US government stockpiles more drugs, refines pandemic surveillance with wastewater sampling and more as it braces for winter.

Coronavirus COVID-19 Distribution

Mayne Knocked Back Again On US NuvaRing Rival

Mayne Pharma has received a further setback in its attempt to bring a generic version of NuvaRing to the US market after the FDA issued the firm with another complete response letter.

Generic Drugs Complete Response Letters

Sandoz Takes Zero-Profit Approach To COVID-19 In Africa

As Sandoz tries to assist African Union member states by selling its pandemic response portfolio medicines for zero profit, mAbxience has partnered with AstraZeneca to produce a vaccine. And CDMO Hovione has struck a deal with Ligand to boost manufacturing of Captisol, a critical ingredient for Gilead’s remdesivir.

Coronavirus COVID-19 Generic Drugs
See All

Company Information

  • Industry
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
  • Other Names / Subsidiaries
    • Alphatec Spine, Inc.
    • Atec Spine
    • SafeOp Surgical
UsernamePublicRestriction

Register